Fellowship, Hematology/Medical Oncology, University of Arizona College of Medicine, Tucson, AZ
Residency, Chief Medical Residency, University of Oklahoma, Oklahoma City, OK
Residency, Internal Medicine, University of Oklahoma, Oklahoma City, OK
Internship, Internal Medicine, University of California, San Diego, La Jolla, CA
MD, Doctor of Medicine, University of California, San Diego, La Jolla, CA
AB, History and Science, Harvard University, Cambridge, MA
1989 to Present:
Oncologist / Hematologist, Marshfield Clinic Inc. - Marshfield Center, Marshfield, WI
1989 to Present:
Attending Physician, Marshfield Clinic Inc. - Minocqua Center, Minocqua, WI
1989 to Present:
Attending Physician, MCHS Hospitals Inc. d/b/a Marshfield Medical Center, Marshfield, WI
1989 to 2016:
Attending Physician, Marshfield Clinic - James Beck Cancer Center, Rhinelander, WI
1987 to 1989:
Military-Lieutenant Colonel and Chief Hematology/Oncology, Medical Corps - United States Air Force Systems Command Regional Hospital, Eglin Air Force Base, FL
1981 to 1985:
Military-Major, Medical Corps (Flight Surgeon) , Oklahoma Air National Guard - 137th Tactical Hospital, Oklahoma City, OK
1977 to 1981:
Military-Captain - Medical Corps (Flight Surgeon), Officer in charge, Flight Medicine, Sernbach Air Base, Federal Republic of Germany, United States Air Force, Germany
1983 to Present:
American Board of Internal Medicine
1986 to Present:
American Board of Internal Medicine Diplomate in Hematology
1987 to Present:
American Board of Internal Medicine Diplomate in Medical Oncology
American College of Physicians, Fellow
American Medical Association, Member
State Medical Society of Wisconsin, Member
American Society of Hematology, Member
American Society of Clinical Oncology, Member
1999 to 2014:
Pharmacy and Therapeutics Committee, Ministry/Saint Joseph's Hospital, Marshfield, WI, Chair
2001 to 2014:
Drug Evaluation Committee, Marshfield Clinic, Marshfield, WI, Chair
Clouse LH, Comp PC. (1985). Proteins C and S: their anticoagulant role and measurement. Lab Management. 23 :29-32.
Clouse LH, Durie BG M, Braich T, Grimm M, Robertone AB. (1986). Interferon alfa-2b-cyclophosphamide combination studies: in vitro and phase I-II clinical results. Semin Oncol. 13 :84-88.
Clouse LH, Braich T, Grimm M, Robertone AB, Durie BG M. (1986). A phase I trial of oral cyclophosphamide (CTX) and subcutaneous recombinant alpha-2b interferon (IFN) in patients with malignant disease. Proceedings of the American Society of Clinical Oncology. 5 :228.
Clouse LH, Comp PC. (1986 May). The regulation of hemostasis: the protein C system. N Engl J Med. 314(20):1298-1304.
Clouse LH. (1989). Adjuvant chemotherapy in colorectal cancer: mournful hopeful perpetual motion machine heads to dim light at end of tunnel. JAMA (Letter). 261 :987-988.
Weiss M, Clouse LH, Nelson B. (1998). Carvedilol associated pancytopenia. BLOOD. 92(Pt 2):91b.
Mazza JJ, Birhiray RE, Clouse LH, Friedenberg WR, Hocking WG, Mercier RJ, Reding DJ. (2001 December). Five-year single institution study of acute adult leukemia. 43rd ASH Annual Meeting.
Hussain K, Mazza JJ, Clouse LH. (2003 March). Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): Case report and review of the literature. Am J Hematol. 72(3):212-215.
Onitilo AA, Engel JM, Clouse LH, Gerndt KM. (2009 February). Successful Treatment of Mitomycin-induced Thrombotic Thrombocytopenic Purpura with Rituximab. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 20(2):275-6.